Department of Otorhinolaryngology, Amsterdam University Medical Centres, location AMC, Amsterdam, The Netherlands.
Royal National Throat, Nose and Ear Hospital, UCLH, London, UK.
Rhinology. 2020 Feb 20;58(Suppl S29):1-464. doi: 10.4193/Rhin20.600.
The European Position Paper on Rhinosinusitis and Nasal Polyps 2020 is the update of similar evidence based position papers published in 2005 and 2007 and 2012. The core objective of the EPOS2020 guideline is to provide revised, up-to-date and clear evidence-based recommendations and integrated care pathways in ARS and CRS. EPOS2020 provides an update on the literature published and studies undertaken in the eight years since the EPOS2012 position paper was published and addresses areas not extensively covered in EPOS2012 such as paediatric CRS and sinus surgery. EPOS2020 also involves new stakeholders, including pharmacists and patients, and addresses new target users who have become more involved in the management and treatment of rhinosinusitis since the publication of the last EPOS document, including pharmacists, nurses, specialised care givers and indeed patients themselves, who employ increasing self-management of their condition using over the counter treatments. The document provides suggestions for future research in this area and offers updated guidance for definitions and outcome measurements in research in different settings. EPOS2020 contains chapters on definitions and classification where we have defined a large number of terms and indicated preferred terms. A new classification of CRS into primary and secondary CRS and further division into localized and diffuse disease, based on anatomic distribution is proposed. There are extensive chapters on epidemiology and predisposing factors, inflammatory mechanisms, (differential) diagnosis of facial pain, allergic rhinitis, genetics, cystic fibrosis, aspirin exacerbated respiratory disease, immunodeficiencies, allergic fungal rhinosinusitis and the relationship between upper and lower airways. The chapters on paediatric acute and chronic rhinosinusitis are totally rewritten. All available evidence for the management of acute rhinosinusitis and chronic rhinosinusitis with or without nasal polyps in adults and children is systematically reviewed and integrated care pathways based on the evidence are proposed. Despite considerable increases in the amount of quality publications in recent years, a large number of practical clinical questions remain. It was agreed that the best way to address these was to conduct a Delphi exercise . The results have been integrated into the respective sections. Last but not least, advice for patients and pharmacists and a new list of research needs are included. The full document can be downloaded for free on the website of this journal: http://www.rhinologyjournal.com.
《欧洲鼻窦炎和鼻息肉 2020 年立场文件》是在 2005 年、2007 年和 2012 年发布的类似循证立场文件的更新版。AR 和 CRS 中提出了 EPOS2020 指南的核心目标,以提供修订后的、最新的和明确的基于证据的建议和综合护理路径。EPOS2020 提供了自 EPOS2012 立场文件发布以来八年中发表的文献和研究的最新情况,并涉及 EPOS2012 中未广泛涵盖的领域,如儿科 CRS 和鼻窦手术。EPOS2020 还涉及新的利益相关者,包括药剂师和患者,并针对自上次 EPOS 文件发布以来更多地参与鼻窦炎管理和治疗的新目标用户,包括药剂师、护士、专门护理人员,实际上是患者自己,他们使用非处方治疗方法越来越多地进行自我管理。该文件提出了该领域未来研究的建议,并为不同环境下的研究提供了更新的定义和结果测量指南。EPOS2020 包含关于定义和分类的章节,我们在其中定义了大量术语并指出了首选术语。提出了一种新的 CRS 分类,将其分为原发性和继发性 CRS,并进一步分为基于解剖分布的局限性和弥漫性疾病。有广泛的章节涉及流行病学和易患因素、炎症机制、(鉴别)面部疼痛、过敏性鼻炎、遗传学、囊性纤维化、阿司匹林加重的呼吸道疾病、免疫缺陷、变应性真菌性鼻窦炎以及上下呼吸道之间的关系。儿科急性和慢性鼻窦炎的章节完全重写。对成人和儿童急性和慢性鼻窦炎(伴或不伴鼻息肉)管理的所有现有证据进行了系统回顾,并提出了基于证据的综合护理路径。尽管近年来高质量出版物的数量大幅增加,但仍有许多实际临床问题尚未解决。大家一致认为,解决这些问题的最佳方法是进行 Delphi 研究。研究结果已纳入相关章节。最后但同样重要的是,为患者和药剂师提供了建议,并列出了新的研究需求。完整的文件可以在本杂志的网站上免费下载:http://www.rhinologyjournal.com。